Delayed Onset Of Tramadol IV Creates Risk Of ‘Opioid Stacking,’ US FDA Finds

 
• By Brenda Sandburg
Injectable drug
US FDA advisory committee to consider new drug application for intravenous tramadol • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers